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Abstract  
Background: The development of effective therapies for acute liver failure (ALF) is 
limited by our knowledge of the pathophysiology of this condition, and the lack of 
suitable large animal models of acetaminophen toxicity. Our aim was to develop a 
reproducible invasively-monitored porcine model of acetaminophen-induced ALF.  
 
Method: 35kg pigs were maintained under general anaesthesia and invasively 
monitored. Control pigs received a saline infusion, whereas ALF pigs received 
acetaminophen intravenously for 12 hours to maintain blood concentrations between 
200-300 mg/l. Animals surviving 28 hours were euthanased.  
 
Results: Cytochrome p450 levels in phenobarbital pre-treated animals were 
significantly higher than non pre-treated animals (300 vs 100 pmol/mg protein). 
Control pigs (n=4) survived 28-hour anaesthesia without incident. Of nine pigs that 
received acetaminophen, four survived 20 hours and two survived 28 hours. Injured 
animals developed hypotension (mean arterial pressure; 40.8+/-5.9 vs 59+/-2.0 
mmHg), increased cardiac output (7.26+/-1.86 vs 3.30+/-0.40 l/min) and decreased 
systemic vascular resistance (8.48+/-2.75 vs 16.2+/-1.76 mPa/s/m3). Dyspnoea 
developed as liver injury progressed and the increased pulmonary vascular resistance 
(636+/-95 vs 301+/-26.9 mPa/s/m3) observed may reflect the development of 
respiratory distress syndrome.  
 
Liver damage was confirmed by deterioration in pH (7.23+/-0.05 vs 7.45+/-0.02) and 
prothrombin time (36+/-2 vs 8.9+/-0.3 seconds) compared with controls. Factor V and 
VII levels were reduced to 9.3 and 15.5% of starting values in injured animals. A 
marked increase in serum AST (471.5+/-210 vs 42+/-8.14) coincided with a marked 
reduction in serum albumin (11.5+/-1.71 vs 25+/-1 g/dL) in injured animals. Animals 
displayed evidence of renal impairment; mean creatinine levels 280.2+/-36.5 vs 
131.6+/-9.33 µmol/l. Liver histology revealed evidence of severe centrilobular 
necrosis with coagulative necrosis. Marked renal tubular necrosis was also seen. 
Methaemoglobin levels did not rise >5%. Intracranial hypertension was not seen (ICP 
monitoring), but there was biochemical evidence of encephalopathy by the reduction 
of Fischer's ratio from 5.6 +/- 1.1 to 0.45 +/- 0.06.  
 
Conclusion: We have developed a reproducible large animal model of 
acetaminophen-induced liver failure, which allows in-depth investigation of the 
pathophysiological basis of this condition. Furthermore, this represents an important 
large animal model for testing artificial liver support systems.
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Background   
Acute liver failure (ALF) is a dramatic clinical syndrome that results from massive 
hepatic necrosis. The mortality of ALF remains high despite progress in the fields of 
intensive care management and liver transplantation (1). ALF refers to the rapid 
development of severe acute liver injury with impaired synthetic function and 
encephalopathy in subjects with previously normal, or well-compensated liver disease 
(2). Generation of a suitable animal model would allow for a greater understanding of 
the underlying pathophysiology of this condition and stimulate the development and 
refinement of treatments for ALF. There is a need for a suitable large animal model of 
hepatic injury to facilitate the development of bio-artificial liver support systems in 
humans and to assist pre-clinical assessment (3). 
 
Since the recognition of acetaminophen–induced ALF in the 1960s, acetaminophen 
overdose has become the commonest cause of liver failure in the United Kingdom (4). 
Although an effective antidote (N-acetylcysteine) has been available for many years, 
the late presentation of many cases ensures a significant number develop liver failure.  
Early large animal models of acetaminophen toxicity were unreliable, producing 
inconsistent toxicity from animal to animal. Gazzard et al (5) showed that dogs 
receiving oral doses greater than 1 g/kg died of nonhepatic causes, becoming cyanotic 
immediately before death with methylene blue-resistant methaemoglobinaemia.   
Human studies have shown that serum acetaminophen levels must be >140 mg/mL 
for greater than 20 hours for consistent hepatic necrosis to occur (6). Using this, 
Francavilla et al (7) studied various doses and dosing schedules on 52 beagle dogs.  
These initially received 750 mg/kg acetaminophen subcutaneously followed by 200 
mg/kg nine hours later, and then a further 200 mg/kg twenty-four hours later. 
Mortality rates in this group were: 0% at 24 hours, 10% at 48 hours, and 90% at 72 
hours. Serum transaminase levels were greatly increased to 8206 +/- 3000 U/L at 48 
hours and 21 253 +/- 3746 U/L at 72 hours. This correlated with liver biopsy samples 
that revealed severe centrilobular necrosis.  
Several approaches have been adopted to control methaemoglobinaemia in animal 
models: Kelly et al (8) using dogs, suspected high plasma acetaminophen levels were 
responsible for the lethal methaemoglobinaemia that characterised their early 
experiments. They controlled acetaminophen infusion in an attempt to maintain its 
levels at 175 to 200 mg/mL for the first 20 hours. Methylene blue was administered at 
10mg/kg if blood samples appeared brown on visual inspection. Pilot data showed 
that levels of acetaminophen greater than 300 mg/mL were associated with severe 
methemoglobinemia.  
 
Cellular glutathione (GSH) levels must be depleted to approximately 20% of their 
original levels before toxic acetaminophen damage can occur, (9, 10). To reduce 
variation in the acetaminophen dose required and the time taken for the development 
of signs, Kelly et al (8) attempted to deplete GSH levels by administering 2 mmol/kg 
of buthionine sulfoximine (BSO) 2 hours before acetaminophen. BSO (11), an 
analogue for glutathione synthetase, binds and irreversibly inactivates this enzyme 
which is the final enzyme in GSH synthesis. The rapid turnover of cellular GSH, 
ensures that enzyme inactivation leads to a rapid reduction in the hepatocyte GSH 
concentrations. Kelly et al (8) showed that BSO administration to mice decreased 
hepatic GSH stores to 15% to 20% of normal within 2 hours. They showed greater 
liver damage in the BSO group in terms of alanine aminotransferase activity, 
prothrombin time, bilirubin level, and histological characteristics. Miller et al (12) 
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administered phenobarbital to induce cytochrome P-450 enzymes and thus potentiate 
subsequent acetaminophen toxicity. This increased liver damage and decreased 
animal survival.  
 
There has been limited success in the development of suitable large animal models of 
acetaminophen induced liver injury. In the study described here we used bed-side 
biochemical and invasive haemodynamic monitoring during acetaminophen-induced 
liver damage in a reproducible and controlled manner.  Using this approach we 
markedly reduced previously reported problems, i.e., methaemoglobinaemia and 
cardiovascular collapse, and produced a large animal model which reliably reproduces 
the syndrome of ALF observed in clinical practice. 
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Methods 
Animal experiments were performed in accordance with the Home Office regulations 
under the Animal (Scientific Procedures) Act 1986 as per Project licence 60/2389. 
All animals received humane care and study protocols complied with our institution's 
guidelines. 
 
13 Large White pigs (median body mass 35 kg) were maintained under. Anaesthesia 
was induced with Ketamine and Midazolam, and subsequently maintained with 
isoflurane and nitrous oxide according to tidal volume. Background hydration was 
maintained at a rate of 2mls/kg/hr using a combination of 0.9% Normal Saline and 
5% Dextrose according to electrolyte results from arterial blood gas sampling and 
urine output. Boluses of colloid (Gelofusine) were administered for episodes of 
hypotension. Heater pads were used to ensure that core (rectal) temperature was 
maintained between 37-39ºC (the normal temperature range for pigs) (13). 
Haemodynamic variables were monitored continuously using a Datex AS/3 
monitoring system (Datex Ohmeda, Stirling, UK) and recorded at one minute 
intervals using the Datex Collect programme on a laptop computer.   Measurements 
were made from arterial, central venous and pulmonary arterial cannulae. The latter 
allowed hourly left atrial pressure (from pulmonary capillary wedge pressure) and 
cardiac output (thermodilution) measurements: 10 mls isotonic saline aliquots at 4°C 
were injected through the injectate port of the pulmonary artery catheter using a 
closed injectate system (CO-Set plus, Baxter Edwards Critical Care, Irvine, CA, 
USA). Three measurements were made at random points during the respiratory cycle 
and an average value taken for each measurement. Intracranial pressure (ICP) was 
monitored with a subdural pressure transducer (Camino 110-4B, Integra Lifesciences 
Corp, New Jersey, USA). Correct positioning was confirmed by obtaining an 
appropriate waveform that fluctuated with ventilation. Urine output was monitored 
via a urethrostomy. Microbiological testing was performed routinely for all animals. 
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Acetaminophen administration 
All animals were pre-treated with phenobarbital 20ml orally per day for 5 days prior 
to each experiment to induce cytochrome p450 enzymes (n=13 pigs). Total 
cytochrome p450 levels were measured using CO difference spectroscopy of sodium 
hydrosulphite samples (14). In nine animals intravenous acetaminophen was 
administered while four animals were used as controls and monitored invasively but 
did not receive any acetaminophen infusions. An initial loading dose of 
acetaminophen was administered by intravenous infusion (0.1875g/kg) followed by 
an infusion for 12 hours (1.8mg/kg/min) with the intention of keeping blood 
acetaminophen concentration between 200-300mg/l (n=9 pigs).  Acetaminophen 
levels were monitored by bed-side testing using the Acetasite system (Indiana, USA). 
Arterial blood gas and lactate levels were measured using a Hewlett Packard I-Stat 
point-of-care blood analysis system. Methaemoglobin was concurrently measured 
spectrophotometrically as previously described (15).  
 
Experiments lasted up to 28 hours, and any animals surviving at this time-point were 
euthanased. Necropsy samples of liver, kidney and brain were then taken. Samples 
were fixed in formalin and embedded in paraffin. Sections were cut at 5microns and 
haematoxylin & eosin stained for routine histological analysis. 
 
Laboratory measurements: 
Standard laboratory assays were used for the measurement of liver and renal function, 
full blood count and coagulation parameters( prothrombin time, factors V,VII,VIII). 
Serum aspartate aminotransferase, albumin, potassium and creatinine analysis were 
measured on an Olympus AU2700 automated analyser (Olympus UK Ltd, Watford, 
UK.) using proprietary diagnostic kits.  
 
NMR spectroscopy  
NMR spectroscopy was used to measure a number of amino acids in serum  to 
calculate Fischer’s ratio (16), which is the ratio of the aromatic amino acids (tyrosine 
and phenylalanine) to branch chain amino acids (leucine, isoleucine and valine). 
Reversal of Fischer’s ratio is a reliable marker of development of encephalopathy in 
an anaesthetised model. Samples for NMR spectroscopy were prepared and analysed 
as described previously (17).  
 
Statistical analysis.  
Results are presented as means ± S.E.M, as analysis demonstrated the data to be 
normally distributed. Significance of the differences between means was assessed 
using the two-sided t test. Two-sided t test was performed to determine the statistical 
difference after 24 hours between the two groups. Values of p < 0.05 were considered 
significant.
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Results 
Cytochrome p450 levels measured in homogenised liver tissue from phenobarbital 
pre-treated animals (n=3 pigs)were significantly higher than in animals which had not 
received phenobarbital (300 +/- 86 vs 100 +/- 31, p=0.01) pmol/mg protein. All 
animals in this study subsequently received phenobarbital 
 
Acetaminophen toxicity and methaemoglobinaemia 
Acetaminophen was administered by intravenous infusion for 12 hours with the 
intention of maintaining blood levels between 200-300mg/l. By accurate monitoring 
of acetaminophen and methaemoglobin levels this was largely accomplished (figure 
1a) although in two (of nine) animals levels exceeded 400mg/l. The consequence of 
high acetaminophen levels, namely an increasing methaemoglobin percentage, is 
demonstrated in figure 1b. In injury 7 we were unable to measure acetaminophen 
levels, and despite following a previously calculated infusion pattern the pig 
developed severe methaemoglobinaemia (peak of 13%). This reinforces the 
importance of close monitoring of acetaminophen levels. In general, 
methaemoglobinaemia (>4%) occurred approximately 2-3 hours after acetaminophen 
levels exceeded 350mg/l. The finding of other groups, i.e., that brown blood 
discolouration presages the development of methaemoglobinaemia was not confirmed 
in the current study. Similarly the use of methylene blue (MB) which has previously 
been described as an effective treatment for methaemoglobinaemia, was associated 
with death within 5 minutes of injection in the single animal of the current study in 
which it was administered.   
 
Animal survival 
Control pigs (n=4) survived the 28 hour anaesthetic without complications, whilst 
only two of the nine injured pigs survived to this time-point (see Figure 2a). Two of 
the animals which received acetaminophen were critically unwell, and were 
euthanased at 25 hours. Three pigs developed a syndrome of multi-organ failure 
(MOF) before death, which is in keeping with the clinical condition (4). Failure of 
two or more organ systems was required for MOF to be confirmed: most commonly 
these were arterial hypotension (refractory to fluid resuscitation) and ventilatory 
failure. Sepsis was confirmed in two pigs by blood culture (Klebsiella pneumoniae 
and Pseudomonas paucimobilis). Refractory hypotension and/or difficulties in 
ensuring successful ventilation led to a joint decision to euthanase pigs. 
 
Cardio respiratory evaluation 
Figures 3a and 3b demonstrate that injured pigs (as opposed to uninjured pigs) 
developed the typical haemodynamic pattern of acute liver injury characterised by 
arterial hypotension (40.8±5.9 vs 59±2.0 mmHg, p=0.16) (MAP, mean arterial 
pressure), increased cardiac output (CO) (7.26±1.86 vs 3.30±0.40 l/min, p=0.01) and 
decreased systemic vascular resistance (SVR) (8.48±2.75 vs 16.2±1.76 mPa·s/m3, 
p=0.03) that was unresponsive to fluid infused in an attempt to maintain normal 
pulmonary arterial occlusion pressures (PAOP) (figure 4). Positive pressure lung 
ventilation was associated with a reduction in total compliance as injury progressed 
and the pulmonary vascular resistance (PVR) (636±95 vs 301±26.9 mPa·s/m3, 
p<0.01) increased in this group (figure 4).  This may have indicated the onset of an 
adult respiratory distress syndrome (ARDS)-like picture.   
 
Laboratory analysis 
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Biochemical analysis revealed a marked increase in serum AST (471.5±210 vs 
42±8.14, p=0.03) in conjunction with a marked reduction in serum albumin 
(11.5±1.71 vs 25±1 g/dL, p=0.03) in injured animals (figure 5a). AST rather than 
ALT was used to quantify liver damage as the assay employed was unable to measure 
porcine ALT from homogenised porcine liver tissue. This hepatic dysfunction was 
confirmed by pH (7.23±0.05 vs 7.45±0.02, p=0.02) and prothrombin time (36±2 vs 
8.87±0.33 seconds, p=0.002) (figure 5b).  Arterial pH decreased significantly in the 
injured group in parallel with increasing prothrombin times (to a mean of 36seconds 
at 24 hours). The liver components of prothrombin time, factors V and VII were 
(figure 6a) to decrease after injury to levels of 9.3% and 15.5% of normal values 
respectively. Factor VIII levels remained unchanged indicating that Disseminated 
intravascular coagulation (DIC) was not the main cause for the altered levels of other 
coagulation factors. 
 
In addition to liver injury there was evidence of renal impairment as shown in figure 7 
where serum creatinine rises above 250µmol/l in injured animals, although serum 
potassium remains below 6mmol/l. Mean levels of creatinine and potassium were 
280.2±36.5 vs 131.6±9.33 µmol/l (p=0.002) and 5.65±0.53 vs 4.6±0.12 mmol/L 
(p=0.27) respectively. 
 
Evidence of encephalopathy: Fischer’s ratio 
In the liver injury group there was a significant increase in tyrosine (0.03 ± 0.004 vs 
0.40 ± 0.02) (p<0.008) and phenylalanine concentrations (0.05 ± 0.004 vs 0.71 ± 
0.08) (p<0.001) by the end of the experiment. There were no statistically significant 
changes in leucine levels (0.17 ± 0.02 vs 0.175 ± 0.02) although isoleucine increased 
significantly (0.08 ± 0.01 vs 0.2 ± 0.01) (p<0.05) while valine levels decreased (0.2 ± 
0.02 vs 0.13 ± 0.01) (p<0.01). Fischer’s ratio (BCAA/AAA) was 5.6 ± 1.1 at the 
beginning and 0.45 ± 0.06 at the end of the study (see Figure 8).  The ratio was 
unchanged in uninjured pigs. 
 
Intracranial pressure (ICP) measurements 
Intracranial pressure did not alter in any of the control or injured animals at any time 
during the experiment. Mean levels were 8mmHg. Cerebral perfusion pressure was 
less in injured animals, principally because of arterial hypotension; this was not 
associated with obvious cerebral histopathology.    
 
Histology 
Histological analysis of liver tissue revealed perivenular and mid-zone confluent 
hepatocytic necrosis in the worst-affected animals, with microvesicular change in 
preserved viable parenchyma. Other animals developed less injury as judged by the 
extent of necrosis, but qualitatively similar patterns (see Figure 9) were seen.  Four 
animals demonstrated moderately severe liver injury, 2 developed severe coagulative 
necrosis and 3 developed mild (no zonal confluent necrosis) liver injury. Similarly, 
renal histopathology of seven pigs revealed severe acute tubular injury as judged by 
the prevalence of vacuolar change to the cortical tubular epithelium. 
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Discussion and Conclusions 
The major role for an ALF model is to provide a more controlled experimental 
environment than currently exists (18). An ideal model should satisfy the following 
criteria: 1) induced hepatic failure should be reversible; 2) the features of liver 
damage should be reproducible; 3) selective damage should lead to fatal liver failure 
over a period similar to that encountered in the human condition; but 4) with 
sufficient time to allow the option for successful treatment; 5) the model should be 
large enough to accommodate anthropocentric therapies; and 6) the toxins used 
should not be hazardous to laboratory personnel.  A pig model would be preferable as 
it has the potential to fulfil all of these criteria, and also importantly shares very 
similar liver metabolic function with human liver (19). 
 
The porcine model described here develops most of the signs typifying acute liver 
injury/failure, namely: tachycardia, hypotension, increased cardiac output, decreased 
systemic vascular resistance, coagulopathy, renal failure and altered hepatic 
biochemistry. Consequently, it is the only animal model of acetaminophen-induced 
liver injury large enough to allow monitoring at a level equivalent to intensive care. 
Whilst the outcome of acetaminophen-injured pigs is relatively reproducible there still 
remain some inherent variations highlighting the difficulty of such studies. This 
reinforces the need to perform large studies when using such animals to ensure that 
individual variations can be accounted for. 
  
Our model showed the typical increase in cardiac output and reciprocal reductions in 
SVR found in the clinical setting. Of note this is accelerated within the porcine model, 
starting within 16 hours of the onset of liver damage. This is likely a reflection of pre-
treatment with phenobarbitone. The increased PVR in the context of normal PaO2 
values was in keeping with the increased requirement for positive end-expiration 
pressure (PEEP) during ventilation.  This may have indicated the onset of an ARDS-
like picture, although lung histology would be important to support this conclusion. 
That PAOP did not increase suggests that the ventilatory changes were not associated 
with pulmonary oedema secondary to left ventricular failure.  A non-significant 
reduction in PVR Index after liver injury has been described (20). The reason for this 
difference is unclear. Acute lung injury is common in patients with acetaminophen-
induced fulminant hepatic failure and is associated with systemic circulatory failure, 
cerebral oedema and high mortality. 
 
The marked reduction in Factor V and VII levels in the current model were consistent 
with severe liver injury. The Clichy criteria (21) deemed a reduction of Factor V 
levels to <20-30% as the trigger for liver transplantation; this was the case in most 
animals in this experiment. The absence of changes in Factor VIII levels indicate DIC 
was not the cause of altered levels of other coagulation factors. 
 
An increase in AST levels indicated the development of liver necrosis, although these 
were not as high as are seen in patients. Similarly, a rise in bilirubin did not occur. 
This may reflect a species-specificity of the assay used, or insufficient time for 
bilirubin to rise. It is possible that there are subtle variations in this model compared 
to humans in that some systemic features prevail over a liver focused pattern of 
injury.  Liver tissue analysis revealed severe coagulative necrosis in some animals 
with moderate and mild injury in others. This supports the probability that significant 
liver injury accounts for the clinical syndrome reported here. Although there is some 
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variability in the liver injury seen in this model, there is still significant liver injury in 
the majority of animals. Indeed, this variation closely mimics what is seen clinically.  
 
There are several explanations for the failure to observe changes in ICP. The time 
course may have been too brief.  However, a raised ICP is not always encountered in 
the clinical setting, or only in association with other factors such as sepsis.  It may 
also reflect differences in the pathophysiology of drug-induced ALF as opposed to 
ischaemic models of ALF. Measurements of arterial ammonia, cerebral blood flow or 
the use of cerebral microdialysis may help to clarify intracranial effects in future 
studies. Biochemical analysis suggested that animals may have been developing 
encephalopathy, although in the absence of ICP changes and with general anaesthesia 
it is difficult to be certain. Fischer’s ratio (16), the ratio of the aromatic amino acid 
(AAA; tyrosine and phenylalanine) to branch chain amino acid (BCAA; leucine, 
isoleucine and valine) concentrations has a value of 3 to 4 in clinical liver failure but 
when this ratio is reversed and is in absolute figures <1.4 then most patients develop 
hepatic encephalopathy.  
 
There was evidence of marked renal impairment, although fatal hyperkalaemia was 
not observed. Renal dysfunction is an important feature of acetaminophen induced 
liver failure (22), and the renal histology in treated animals was consistent with a 
toxic injury rather than the distinctive pattern of frank outer medullary tubular 
necrosis encountered with ischaemia, i.e., critical hypotension. 
 
Methaemoglobinaemia.  
This study demonstrates the importance of continuous monitoring of acetaminophen 
levels, the one animal from which it was withheld died from methaemoglobinaemia. 
The amount of acetaminophen required to maintain levels between 200-300mg/l for 
12 hours was calculated beforehand, but it was necessary in every case to reduce the 
infusion rate (and the total dose administered) as acetaminophen levels exceeded this 
range.   Levels greater than 250mg/l increased serum methaemoglobin levels, although 
this usually resolved by stopping the acetaminophen infusion which allowed plasma 
levels to fall. Acetaminophen and its intermediates oxidise haemoglobin to 
methaemoglobin, which is unable to carry oxygen. Although it occurs in human 
beings, it is less marked than in cats, dogs, and pigs. In some species, methemoglobin 
is reduced to hemoglobin by the methemoglobin reductase using reduced glutathione 
(GHS) as a substrate. GSH itself is recycled by the glutathione reductase, using 
reduced nicotinamide-adenine dinucleotide phosphate (NADPH) from the pentose 
phosphate pathway. Due to the glucose impermeability of porcine red blood cells 
(compared with rats and rabbits) there is a diminution in generation of NADPH and 
hence decreased reduction of methaemoglobin (23). Levels of methaemoglobinaemia 
in pigs (24) administered acetaminophen are only one-half those reported in cats (25) 
and dogs (26).  There are several measures to control methaemoglobin levels in 
animal models.  Kelly et al (8) suspected high plasma acetaminophen levels were 
responsible for lethal methaemoglobinaemia and so tried to prevent them.  Not having 
access to bedside testing and thus being unable to prevent high acetaminophen levels 
they administered MB at 10mg/kg if the blood appeared brown on visual inspection.  
The usefulness of this strategy was not confirmed in the current study. 
 
Methylene blue is the recognized clinical treatment for methaemoglobinaemia and 
acts by reducing methaemoglobin back to haemoglobin. Its action depends on the 
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availability of adequate NADPH concentrations within the erythrocyte; a deficiency 
of NADPH availability leads to further methaemoglobinaemia.  On the single 
occasion it was used in the current study the animal died of cardiovascular collapse 5 
minutes later.  
 
Presence of anaemia. Miller et al (12) found that the haematocrit fell rapidly (25% 
decrease from the initial packed cell volume) in sixty percent of animals 1 to 2 hours 
before death.  The cause of anaemia in their study was unclear, and may reflect 
extravascular haemolysis within the spleen.  The haemoglobin nor haematocrit levels 
did not fall in either the control nor the treatment groups in the current study. 
 
In summary, we have described the first intensively monitored porcine model of 
acetaminophen-induced severe liver injury which displays most of the features seen in 
the human condition.  This large animal model can play an important role in the 
evaluation of the effectiveness of liver support systems, as well as providing us with 
the ability to develop a much better understanding of the pathophysiology of this 
devastating clinical syndrome.  
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Figure legends 
 
Figure 1 Acetaminophen concentrations (A) and Methaemoglobin levels (B) in 
pigs following acetaminophen administration. 
 
Panel A. Acetaminophen levels for individual pigs are noted, with the corresponding 
methaemoglobin levels illustrated in panel B. Acetaminophen levels of between 200 
300mg/l were aimed for although even with frequent measurements and reductions in 
the infusion rate there were rises often to 400mg/l. Prolonged elevation of levels 
above 300mg/l did lead to a rise in methaemoglobin. For pig 7 facilities to measure 
acetaminophen levels were unavailable and this led to a marked rise in 
methaemoglobin levels. 
 16
Figure 2 Kaplan Meier survival curve for control and acetaminophen injured 
pigs 
 
 (A) The control group (Group 0) as demonstrated by the uninterrupted line all 
survived, and indeed appeared healthy when euthanased. The injury group (Group 1) 
as demonstrated by the interrupted line died as denoted in the Kaplan-Meier curve. 
Two animals* were euthanased at 25 hours as they appeared particularly unwell, and 
another further two were euthanased at the end of the experiment with no obvious ill 
effects from acetaminophen administration. 
 
(B) This table outlines the likeliest cause of death along with a correlation with the 
amount of liver and renal injury. In most cases the cause of death was multi-organ 
failure (MOF) with evidence of hypotension, marked oedema, oliguria and ventilatory 
difficulties. In two animals organisms were identified in routine blood cultures. In pig 
2 a cavitating lung abscess was identified although this was in addition to liver and 
renal injury. However in pig 9 Pseudomonas paucimobilis was identified in blood 
cultures with little evidence of significant renal or liver damage. +++ covered severe 
hepatic coagulative necrosis, ++ covered moderate hepatic coagulative necrosis and + 
covered mild hepatic coagulative necrosis. Similarly the scoring scale for renal injury 
covered the range from mild (+) to moderate (++) to severe (+++) tubular necrosis. 
 
Pig 7 developed significant methaemoglobinaemia (>10%). Administration of 
Methylene blue led to circulatory collapse and death within 5 minutes. Pig 8 had 
moderately elevated levels of methaemoglobinaemia (>4%), and shortly before death 
dropped its oxygen saturations to 40%. No additional contributory cause to death was 
identified. 
 17
Figure 3 Profile of Pulse, Mean Arterial pressure, Cardiac Output and Systemic 
Vascular Resistance in control and acetaminophen injured pigs 
 
Chart A demonstrates a progressive increase in pulse and concomitant reduction in 
MAP following liver injury. Furthermore, chart B demonstrates a marked increase in 
cardiac output (CO) and decreased systemic vascular resistance (SVR) following liver 
injury. These haemodynamic changes are in keeping with the multi-organ failure seen 
in acute liver injury. 
 18
Figure 4 Profile of Pulmonary Artery Occlusion Pressure and Pulmonary 
Vascular Resistance in control and acetaminophen injured pigs 
 
Fluid resuscitation was guided by Pulmonary Artery Occlusion Pressure (PAOP), and 
therefore this was similar between the two groups. Pulmonary Vascular Resistance 
(PVR) became noticeably higher in the acetaminophen injured pigs. This was also 
seen in an increased ventilatory requirement in the latter stages of the injury 
experiments. 
 19
Figure 5 Profile of serum AST, serum Albumin, arterial pH and plasma 
Prothrombin time in control and acetaminophen injured pigs 
 
Panel A depicts the increase in serum AST and concomitant reduction in serum 
albumin in acetaminophen injured pigs. This pattern of liver injury was also seen in 
panel B, where arterial pH drops and Prothrombin time increases.  
 20
Figure 6 Profile of the plasma coagulation factors V and VII in control and 
acetaminophen injured pigs 
 
The levels of plasma coagulation factors V and VII can be seen to markedly reduce in 
acetaminophen injured pigs in keeping with the previously observed prolongation of 
prothrombin time. 
 21
Figure 7 Profile of serum Creatinine and Potassium in control and 
acetaminophen injured pigs 
 
This panel depicts the development of renal injury in acetaminophen injured pigs as 
assessed by serum Creatinine and Potassium. 
 22
Figure 8 Fischer’s ratio in acetaminophen injured pigs 
 
Fischer’s ratio, a ratio of the concentrations of aromatic amino acids (tyrosine and 
phenylalanine) to branch chain amino acids (leucine, isoleucine and valine) is 
demonstrated in the panel. There was no change in the control animal group, but after 
liver injury there was a marked reduction. 
 23
Figure 9 Histology 
 
This figure depicts representative photographs of liver and renal sections. Panel a, 
represents liver tissue taken from a control pig. Panel b represents liver tissue taken 
from pig 4 and demonstrates moderate injury. There is diffuse microvesicular change, 
with moderately severe centrilobular necrosis. Panels c and d (higher power) 
represents liver tissue taken from pig 7 demonstrating more severe coagulative 
centrilobular necrosis. Panel e represents renal tissue taken from a control pig. Panel f 
represents liver tissue taken from pig 7 demonstrating severe vacuolar injury to the 
cortical tubules in keeping with the development of acute tubular necrosis. 
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